Frequency of somatic TP53 mutations in non-small cell lung cancer in Kazakhstan

被引：0
|
作者：
Zhuraliyeva, A. [1 ]
Wang, J. [2 ]
Khamdiyeva, O. [1 ]
Abdullaev, Z. [2 ]
Pack, S. [2 ]
Biyasheva, Z. [1 ]
机构：
[1] Al Farabi Kazakh Natl Univ, Sci Res Inst Issues Biol & Biotechnol, Alma Ata, Kazakhstan
[2] NCI, Pathol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA
来源：
FEBS OPEN BIO | 2019年 / 9卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P-35-114
引用
收藏
页码：354 / 354
页数：1
相关论文
共 50 条
  • [21] Impact of TP53 mutations on efficacy of PD-1 targeted immunotherapy in non-small cell lung cancer (NSCLC).
    Carlisle, Jennifer Wilkinson
    Nhu Thi Nho
    Kim, Chaejin
    Chen, Zhengjia
    Li, Shiyong
    Hill, Charles
    Ramalingam, Suresh S.
    Sica, Gabriel
    Owonikoko, Taofeek Kunle
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [22] Increased Tissue Factor Expression Is Associated with Reduced Survival in Non-Small Cell Lung Cancer and with Mutations of TP53 and PTEN
    Regina, Sandra
    Valentin, Jean-Baptiste
    Lachot, Sebastien
    Lemarie, Etienne
    Rollin, Jerome
    Gruel, Yves
    CLINICAL CHEMISTRY, 2009, 55 (10) : 1834 - 1842
  • [23] Impact of TP53 mutations on brain metastasis control in non-small cell lung cancer patients undergoing stereotactic radiosurgery
    Leng, Jim X.
    Su, Chang
    Carpenter, David J.
    Floyd, Warren
    Vaios, Eugene
    Shenker, Rachel
    Hendrickson, Peter G.
    Giles, Will
    Mullikin, Trey
    Floyd, Scott R.
    Kirkpatrick, John P.
    Green, Michelle
    Reitman, Zachary J.
    JOURNAL OF RADIOSURGERY AND SBRT, 2024, 9 (02):
  • [24] TP53 Mutations Could Involve in EGFR-TKI Primary Resistance in Advanced Non-Small Cell Lung Cancer
    Li, X.
    Su, C.
    Ren, S.
    Zhao, C.
    Jiang, T.
    Chen, X.
    Li, J.
    Li, W.
    Gao, G.
    Zhou, F.
    Shao, Y.
    Zhou, C.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2227 - S2227
  • [25] Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer
    Sanchez-Cespedes, M
    Reed, AL
    Buta, M
    Wu, L
    Westra, WH
    Herman, JG
    Yang, SC
    Jen, J
    Sidransky, D
    ONCOGENE, 1999, 18 (43) : 5843 - 5849
  • [26] The Influence of TP53 Mutations on the Prognosis of Patients With Early Stage Non-Small Cell Lung Cancer May Depend on the Intratumor Heterogeneity of the Mutations
    Lee, Shin Yup
    Jeon, Hyo-Sung
    Hwangbo, Yup
    Jeong, Ji Yun
    Park, Ji Young
    Lee, Eun Jin
    Jin, Guang
    Shin, Kyung Min
    Yoo, Seung Soo
    Lee, Jaehee
    Lee, Eung Bae
    Cha, Seung Ick
    Kim, Chang Ho
    Park, Jae Yong
    MOLECULAR CARCINOGENESIS, 2015, 54 (02) : 93 - 101
  • [27] Immunohistochemical correlates of TP53 somatic mutations in cancer
    Murnyak, Balazs
    Hortobagyi, Tibor
    ONCOTARGET, 2016, 7 (40) : 64910 - 64920
  • [28] PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers
    Jin, Guang
    Kim, Min Jung
    Jeon, Hyo-Sung
    Choi, Jin Eun
    Kim, Dong Sun
    Lee, Eung Bae
    Cha, Sung Ick
    Yoon, Ghil Sook
    Kim, Chang Ho
    Jung, Tae Hoon
    Park, Jae Yong
    LUNG CANCER, 2010, 69 (03) : 279 - 283
  • [29] Profiling the Metastatic Potential of Non-Small Cell Lung Cancer Patients Based on TP53 Classification
    Lu, J.
    Lou, Y.
    Zhong, R.
    Sun, J.
    Zhong, H.
    Han, B.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S513 - S513
  • [30] Prognostic value of KIF2A and TP53 overexpression in non-small cell lung cancer
    Zhou, Xiaoyu
    Lu, Chenlin
    Shi, Jiahai
    Huang, Fang
    Jin, Qin
    Feng, Jian
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (07): : 7266 - 7275
12345